Transactions
Our reputation for deal acumen comes from sophisticated multidisciplinary thinking and our close, longstanding working relationships with clients, guiding them in their most important transactions.

Overview

We work with multinationals and many of Canada’s largest and most influential companies and investors on significant and transformational transactions. Clients get a true partner in their work with Torys: strategic deal teams with deep technical ability, broad multidisciplinary insight and informed perspective to get transactions done across industries and geographies.

We tap the broader firm’s wealth of corporate, compliance and regulatory knowledge to benefit our clients' goals. Our decades-long experience in Toronto, New York, Calgary and Montréal reflects our distinguished and diverse client base, which is engaged in deal activity across Canada, the U.S. and globally. With full-service capabilities on both sides of the Canada-U.S. border, we are uniquely positioned to advise as a single firm on cross-border and international transactions.

Areas of Service

We bring novel thinking and clarity to execute clients’ transactions efficiently across Canada and around the world.
We are active dealmakers.
Clients turn to us for their largest, most complex transactions. In the last two years, we have advised on transactions totaling in excess of $500 billion.
Our reach is global.
We support clients across markets and geographies, advising leading organizations on their transactions in Canada, the U.S. and globally. We serve half of Canada’s top 100 public companies.
>$500B
Deal value in the last two years
$90B
Public offerings since 2018
53
Jurisdictions covered since 2018

Representative Work

They make us feel like their favourite client. All of the lawyers we work with there are extremely responsive, solutions oriented, efficient and smart. We always feel we get great value from the team and consider Torys to be an important partner in our business.
— The Legal 500, 2021

Subscribe and stay informed

Stay in the know. Get the latest commentary, updates and insights for business from Torys.

Subscribe Now